Senate HELP focuses on measles, vaccine policy while questioning three HHS nominees

# What happened Three Trump administration health nominees appeared before the Senate Health, Education, Labor and Pensions (HELP) Committee. The hearing focused on the current U.S. measles outbreak, questions about vaccine safety, how nominees would respond to presidential instructions that might break the law, and HHS responsiveness to congressional requests.

# Who testified

• Nicole Saphier, M.D., nominee for surgeon general. She currently practices radiology and is the director of breast imaging at a Memorial Sloan Kettering facility in Middletown, New Jersey.
• Chris Klomp, nominee for deputy secretary of the U.S. Department of Health and Human Services (HHS).
• Timothy Westlake, M.D., nominee for assistant secretary for Mental Health and Substance Use.

# Central lines of questioning Senators repeatedly returned to measles and vaccine policy. Committee Chairman Bill Cassidy opened by citing a measles outbreak tied to four deaths in Pennsylvania and criticized political figures who give medical advice that lacks scientific support. He pressed nominees to make plain public-health positions rather than use equivocation.

Cassidy asked Saphier whether she would say the MMR vaccine causes autism. She declined to identify a cause of autism but stated she had not seen reputable evidence that vaccines cause autism, and later said she does not believe childhood vaccines cause autism.

Multiple senators asked whether nominees would follow the law if the president directed actions that would break it. Saphier said she had "no intention of breaking the law." Westlake said his "ultimate responsibility is to the American people" and that he follows the law. Klomp faced similar questioning in a separate Finance Committee session.

Sen. Tammy Baldwin pushed nominees on whether public-health leaders would prioritize science and the law over political pressures. She said past nominees pledged to do so but that she has seen little evidence of durable independence.

# Operational concerns and measles data Senators also questioned HHS responsiveness to congressional letters and information requests. Sen. Tim Kaine said multiple letters have gone unanswered and asked how Klomp would improve responsiveness. Klomp acknowledged the high volume of requests but said there are operational improvements that could be made and that he would work on the issue if confirmed.

On the question of measles deaths, Klomp said he discussed the issue with CDC Director Erica Schwartz, M.D., and identified two deficiencies: the need for a clear, authoritative definition of "death by measles" and better operational transparency. He recommended publishing definitions and data on the CDC website and then centering debate on policy responses—specifically promoting vaccination to maintain elimination status.

# What comes next Westlake's nominations to advance to a full Senate vote. Klomp's confirmation will proceed through the Senate Finance Committee. Baldwin noted that additional written questions for nominees were due by 5 p.m. Thursday.

# Why this matters Senate scrutiny centered on whether nominees will defend established public-health practice and data transparency amid a large measles outbreak and public disagreement between federal and state officials. The nominees' answers on vaccine safety, legal obligations, and operational reform give senators a basis to evaluate whether they will follow scientific consensus and improve departmental responsiveness if confirmed.